Literature DB >> 16775487

CD4+CD25+ cell depletion from the normal CD4+ T cell pool prevents tolerance toward the intestinal flora and leads to chronic colitis in immunodeficient mice.

Claudia Veltkamp1, Rebecca Ruhwald, Thomas Giesem, Frank Autschbach, Ines Kaden, Roland Veltkamp, R Balfour Sartor, Wolfgang Stremmel.   

Abstract

BACKGROUND: CD4+CD25+ regulatory T cells have been shown to prevent immune-mediated colitis in mice; however, it is unclear whether the absence of CD4+CD25+ in the normal CD4+ T cell pool is responsible for the development of chronic colitis. Using the T cell-deficient Tgepsilon26 mouse model, we show that CD4+CD25- cells but not CD4+CD25+ cells induce a severe intestinal inflammation. Transfer of CD4+CD25+ cells, together with CD4+CD25- cells, ameliorated intestinal inflammation, and reconstitution with the whole mesenteric lymph node cell pool did not induce colitis in recipients. Transferred CD4+CD25- cells were found mainly in the mesenteric lymph nodes, where they showed an activated TH1-like phenotype. In the absence of regulatory CD4+CD25+ T cells, recipient CD4 cells secreted IFN-gamma in response to stimulation with intestinal bacterial antigen that was prevented in vivo and in vitro by regulatory CD4+CD25+ cells. These studies suggest that CD4+CD25- cells have a strong colitogenic effect in the Tgepsilon26 colitis model and that CD4+CD25+ cells may be the main regulators that prevent or downregulate the proinflammatory effect of colitogenic T cells in the Tgepsilon26 mouse model.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16775487     DOI: 10.1097/00054725-200606000-00002

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  16 in total

1.  Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratios.

Authors:  Jörn-Hendrik Weitkamp; Tatsuki Koyama; Michael T Rock; Hernan Correa; Jeremy A Goettel; Pranathi Matta; Kyra Oswald-Richter; Michael J Rosen; Brian G Engelhardt; Daniel J Moore; D Brent Polk
Journal:  Gut       Date:  2012-01-20       Impact factor: 23.059

Review 2.  Immunopathogenesis of IBD: insufficient suppressor function in the gut?

Authors:  I L Huibregtse; A U van Lent; S J H van Deventer
Journal:  Gut       Date:  2006-10-17       Impact factor: 23.059

Review 3.  Epithelia: lymphocyte interactions in the gut.

Authors:  Stephanie Dahan; Franziska Roth-Walter; Paul Arnaboldi; Shradha Agarwal; Lloyd Mayer
Journal:  Immunol Rev       Date:  2007-02       Impact factor: 12.988

4.  Lactobacillus reuteri DSM 17938 differentially modulates effector memory T cells and Foxp3+ regulatory T cells in a mouse model of necrotizing enterocolitis.

Authors:  Yuying Liu; Dat Q Tran; Nicole Y Fatheree; J Marc Rhoads
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-05-22       Impact factor: 4.052

5.  Intravenous injection of endogenous microbial components abrogates DSS-induced colitis.

Authors:  Beate C Sydora; Eric J Albert; Rae R Foshaug; Jason S G Doyle; Thomas A Churchill; Richard N Fedorak
Journal:  Dig Dis Sci       Date:  2011-09-01       Impact factor: 3.199

6.  Mesenteric injection of adipose-derived mesenchymal stem cells relieves experimentally-induced colitis in rats by regulating Th17/Treg cell balance.

Authors:  Zheng-Wei Fu; Zhen-Yu Zhang; Hai-Yan Ge
Journal:  Am J Transl Res       Date:  2018-01-15       Impact factor: 4.060

7.  Citrobacter-induced colitis in mice with murine acquired immunodeficiency syndrome.

Authors:  T N Fredrickson; J W Hartley; H C Morse
Journal:  Vet Pathol       Date:  2010-01-29       Impact factor: 2.221

8.  Ontogeny of FOXP3(+) regulatory T cells in the postnatal human small intestinal and large intestinal lamina propria.

Authors:  Jörn-Hendrik Weitkamp; Erin Rudzinski; Tatsuki Koyama; Hernan Correa; Pranathi Matta; Brannon Alberty; D-Brent Polk
Journal:  Pediatr Dev Pathol       Date:  2009 Nov-Dec

9.  Mapping the New World of Necrotizing Enterocolitis (NEC): Review and Opinion.

Authors:  Phillip Gordon; Robert Christensen; Jörn-Hendrik Weitkamp; Akhil Maheshwari
Journal:  EJ Neonatol Res       Date:  2012

10.  Epigallocatechin-3-gallate-induced inhibition of interleukin-6 release and adjustment of the regulatory T/T helper 17 cell balance in the treatment of colitis in mice.

Authors:  Zhenglei Xu; Cheng Wei; R U Zhang; Jun Yao; Dinguo Zhang; Lisheng Wang
Journal:  Exp Ther Med       Date:  2015-10-23       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.